OBJECTIVE: The objective of this study is to determine the number of primary stroke centers (PSCs) that exist concurrently (synergic relationship) with designated higher level trauma centers (level I or level II trauma centers) and associated characteristics. METHODS: We identified all PSCs certified by the Joint Commission or local state authorities in 2010. Concurrently, all the higher level trauma centers (designated level I or level II) were identified using data collected from the trauma information exchange program. Additional data was collected from the Accreditation Council for Graduate Medical Education and the American hospital directory. RESULTS: A total of 788 existing designated PSCs were identified in 2010; coexisting PSC-trauma centers were found in 252 centers (32%) with PSCs coexisting with level I trauma centers in 138 hospitals (17.5%). The remaining 536 PSCs (68%) are based in hospitals without trauma centers. There was a higher proportion of residency training programs including neurology, neurosurgery, and general surgery in coexisting PSC-trauma centers (P < .001). In a proof-of-concept analysis in 1 state, PSCs with level I trauma facilities were found to have the highest rates of thrombolytic administration as compared with PSCs with level II trauma centers and PSCs without trauma facilities (12.8% vs 3.8% vs 4.9%)(P < .0001). Primary stroke centers with level I trauma facilities were also more likely to follow the drip-and-ship paradigm (5.7% vs 1.8% vs 0.9%) (P < .0001). CONCLUSIONS: Despite evidence of higher capability among institutions with coexisting PSC-trauma centers, two thirds of PSCs are in hospitals without advanced trauma systems. These findings have implications for establishing stroke systems in the United States.
OBJECTIVE: The objective of this study is to determine the number of primary stroke centers (PSCs) that exist concurrently (synergic relationship) with designated higher level trauma centers (level I or level II trauma centers) and associated characteristics. METHODS: We identified all PSCs certified by the Joint Commission or local state authorities in 2010. Concurrently, all the higher level trauma centers (designated level I or level II) were identified using data collected from the trauma information exchange program. Additional data was collected from the Accreditation Council for Graduate Medical Education and the American hospital directory. RESULTS: A total of 788 existing designated PSCs were identified in 2010; coexisting PSC-trauma centers were found in 252 centers (32%) with PSCs coexisting with level I trauma centers in 138 hospitals (17.5%). The remaining 536 PSCs (68%) are based in hospitals without trauma centers. There was a higher proportion of residency training programs including neurology, neurosurgery, and general surgery in coexisting PSC-trauma centers (P < .001). In a proof-of-concept analysis in 1 state, PSCs with level I trauma facilities were found to have the highest rates of thrombolytic administration as compared with PSCs with level II trauma centers and PSCs without trauma facilities (12.8% vs 3.8% vs 4.9%)(P < .0001). Primary stroke centers with level I trauma facilities were also more likely to follow the drip-and-ship paradigm (5.7% vs 1.8% vs 0.9%) (P < .0001). CONCLUSIONS: Despite evidence of higher capability among institutions with coexisting PSC-trauma centers, two thirds of PSCs are in hospitals without advanced trauma systems. These findings have implications for establishing stroke systems in the United States.
Authors: Mark J Alberts; Richard E Latchaw; Warren R Selman; Timothy Shephard; Mark N Hadley; Lawrence M Brass; Walter Koroshetz; John R Marler; John Booss; Richard D Zorowitz; Janet B Croft; Ellen Magnis; Diane Mulligan; Andrew Jagoda; Robert O'Connor; C Michael Cawley; J J Connors; Jean A Rose-DeRenzy; Marian Emr; Margo Warren; Michael D Walker Journal: Stroke Date: 2005-06-16 Impact factor: 7.914
Authors: Lee H Schwamm; Arthur Pancioli; Joe E Acker; Larry B Goldstein; Richard D Zorowitz; Timothy J Shephard; Peter Moyer; Mark Gorman; S Claiborne Johnston; Pamela W Duncan; Phil Gorelick; Jeffery Frank; Steven K Stranne; Renee Smith; William Federspiel; Katie B Horton; Ellen Magnis; Robert J Adams Journal: Stroke Date: 2005-02-02 Impact factor: 7.914
Authors: J R Marler; B C Tilley; M Lu; T G Brott; P C Lyden; J C Grotta; J P Broderick; S R Levine; M P Frankel; S H Horowitz; E C Haley; C A Lewandowski; T P Kwiatkowski Journal: Neurology Date: 2000-12-12 Impact factor: 9.910
Authors: M J Alberts; G Hademenos; R E Latchaw; A Jagoda; J R Marler; M R Mayberg; R D Starke; H W Todd; K M Viste; M Girgus; T Shephard; M Emr; P Shwayder; M D Walker Journal: JAMA Date: 2000-06-21 Impact factor: 56.272
Authors: Susan Unipan Lattimore; Julio Chalela; Lisa Davis; Thomas DeGraba; Mustapha Ezzeddine; Joseph Haymore; Paul Nyquist; Alison E Baird; John Hallenbeck; Steven Warach Journal: Stroke Date: 2003-05-15 Impact factor: 7.914
Authors: Adnan I Qureshi; M Fareed K Suri; Abu Nasar; Jawad F Kirmani; Mustapha A Ezzeddine; Afshin A Divani; Wayne H Giles Journal: Stroke Date: 2007-05-24 Impact factor: 7.914